“And the other thing we have to do is create new bidding procedures for the drug industry, because they’re getting away with murder.” – Donald Trump



Since the surprise election of Donald Trump, many industries and individual companies have been on the receiving end of his comments during speeches, interviews, and tweets. At his January 11, 2017 news conference, one industry, in particular, was the target of his wrath: US pharma. The quote at the start of this article, taken from a much larger tirade against the drug industry, is typical of President Trump’s recent comments against the pharma industry. Pharmaceutical and biotech stock indices, as well as stock prices of specific companies with high-priced portfolios of specialty medicines, dropped 2 to 4 percent after the news conference, on top of other previous comments made immediately after the election lamenting high drug prices (1),(2),(3).